Bio-Gate AG Paves the Way for Further Growth

July 14, 2026

Bio-Gate AG, headquartered in Nuremberg, where it also operates its laboratory and development center, specializes in technologies that can be used to impart antiviral, antimicrobial, or biologically active properties to materials and surfaces. The company enhances products for a variety of applications and aims to sustainably improve safety, health, and quality of life.

At the Annual Shareholders’ Meeting on June 30, 2026, the shareholders reaffirmed the company’s strategic focus on medical technology, dermocosmetics, and wound care. The company is thus setting the course for its next phase of growth and focusing on the further development of its key areas of innovation.

A key component of the growth strategy is the HyProtect™ coating for orthopedic implants. This surface treatment is designed to help reduce implant-associated infections. With the scheduled launch of a clinical trial in collaboration with an internationally active implant manufacturer in early June, an important milestone was reached on the path to CE approval for HyProtect™-coated revision implants. As things stand, the market launch is scheduled for 2028.

Bio-Gate AG is also advancing its developments in the fields of dermocosmetics and wound care. Together with a partner, the company is working toward the approval of the MicroSilver BG™ wound spray as a medical device for the treatment of chronic and hard-to-heal wounds. With these advances, the health technology company underscores its commitment to bringing innovative solutions to market in a targeted manner and to consistently building on its leading position in these future-oriented markets.

With its expertise in the functional finishing of materials and surfaces, Bio AG enriches the Bayern Innovativ partner network with valuable insights. The company’s developments exemplify how innovative technologies can successfully make their way from research through clinical trials to market launch. It is precisely this transfer of knowledge and innovation into practice that is at the heart of Bayern Innovativ’s networking efforts. As a health innovation network, Bayern Innovativ brings together stakeholders with diverse expertise from business, science, and the healthcare sector, creating opportunities for interdisciplinary exchange. This fosters new collaborations, joint development projects, and needs-based solutions to the challenges facing the healthcare sector.